Evidence map›Paper›PMID 20227666›Full record

ArticleCell host & microbe2010

The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription.

Sara Pagans, Steven E Kauder, Katrin Kaehlcke, Naoki Sakane, Sebastian Schroeder, Wilma Dormeyer, Raymond C Trievel, Eric Verdin, Martina Schnolzer, Melanie Ott

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. [Research Progress of Role and Mechanism of SETD7 in Tumor Occurrence 
and Progression].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Genetic variation and function of the HIV-1 Tat protein.Medical microbiology and immunology · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Sara PagansGladstone Institute of Virology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.
Steven E Kauder
Katrin Kaehlcke
Naoki Sakane
Sebastian Schroeder
Wilma Dormeyer
Raymond C Trievel
Eric Verdin
Martina Schnolzer
Melanie Ott
University of California, San Francisco · USGerman Cancer Research Center · DEGladstone Institutes · USUniversity of Michigan–Ann Arbor · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Role of Factor Acetylation in the Regulation of HIV TranscriptionR01AI083139 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI OTT, MELANIE MARIA · 2009 to 2017
$3.9M
NIAID NIH HHS 1R01AI083139NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI083139
6 · The paper itself

Abstract

The Tat protein of HIV-1 plays an essential role in HIV gene expression by promoting efficient elongation of viral transcripts. Posttranslational modifications of Tat fine-tune interactions of Tat with cellular cofactors and TAR RNA, a stem-loop structure at the 5' ends of viral transcripts. Here, we identify the lysine methyltransferase Set7/9 (KMT7) as a coactivator of HIV transcription. Set7/9-KMT7 associates with the HIV promoter in vivo and monomethylates lysine 51, a highly conserved residue located in the RNA-binding domain of Tat. Knockdown of Set7/9-KMT7 suppresses Tat transactivation of the HIV promoter, but does not affect the transcriptional activity of methylation-deficient Tat (K51A). Set7/9-KMT7 binds TAR RNA by itself and in complex with Tat and the positive transcription elongation factor P-TEFb. Our findings uncover a positive role for Set7/9-KMT7 and Tat methylation during early steps of the Tat transactivation cycle.

Indexed as

HIV Long Terminal RepeatHost-Pathogen InteractionsTranscription, GeneticGene Knockdown TechniquesHeLa CellsHistone-Lysine N-MethyltransferaseHIV-1HumansMethylationPositive Transcriptional Elongation Factor BProtein BindingProtein Processing, Post-TranslationalRNA, Viraltat Gene Products, Human Immunodeficiency VirusHistone-Lysine N-MethyltransferasePositive Transcriptional Elongation Factor BRNA, Viraltat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID20227666
PMCPMC2844784
OpenAlexW2023272972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.